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Abstract
Background and Purpose: Several magnetic resonance imaging (MRI) techniques are being exploited to measure brain iron
levels increasingly as iron deposition has been implicated in some neurodegenerative diseases. However, there remains no
unified evaluation of these methods as postmortem measurement isn’t commonly available as the reference standard. The
purpose of this study was to make a comparison among these methods and try to find a new index of brain iron.
Methods: We measured both phase values and R2* in twenty-four adults, and performed correlation analysis among the
two methods and the previously published iron concentrations. We also proposed a new method using magnitude signal
intensity and compared it with R2* and brain iron.
Results: We found phase value correlated with R2* in substantia nigra (r=20.723, p,0.001) and putamen (r=20.514,
p=0.010), while no correlations in red nucleus (r=20.236, p=0.268) and globus pallidus (r=20.111, p=0.605). And the
new magnitude method had significant correlations in red nucleus (r=20.593, p=0.002), substantia nigra (r=20.521,
p=0.009), globus pallidus (r=20.750, p,0.001) and putamen (r=20.547, p=0.006) with R2*. A strong inverse correlation
was also found between the new magnitude method and previously published iron concentrations in seven brain regions
(r=20.982, P,0.001).
Conclusions: Our study indicates that phase value may not be used for assessing the iron content in some brain regions
especially globus pallidus. The new magnitude method is highly consistent with R2* especially in globus pallidus, and we
assume that this approach may be acceptable as an index of iron content in iron-rich brain regions.
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Introduction
Iron plays important roles in many biological processes ranging
from facilitating cellular aerobic metabolism to participating in
neurotransmitter synthesis and myelin production [1–4]. However,
if iron is not properly regulated, it can be detrimental to neurons
and contributes to the pathogenesis of many neurological diseases.
Abnormal brain iron accumulation has been reported in many
neurodegenerative diseases including Parkinson’s disease, multiple
systems atrophy, Huntington’s disease, Alzheimer diseases, neuro-
ferritinopathy and Hallervorden–Spatz disease and suggests that
iron burden contributes to age- and disease-related functional
decline, which thus represents potent targets for pharmacological
manipulation to limit the progression of those diseases [5–10].
Moreover, iron content in the brain and hematoma are causally
related to delayed neuronal injury and edema formation after
intracranial hemorrhage [11–14]. Therefore, it is believed that the
ability to quantitatively assess regional brain iron has a potential
role in the diagnosis of disease, as well as understanding pa-
thogenesis, disease progression and the monitoring of treatment.
There has been considerable interest in the use of MR imaging
to assess iron concentration in the human brain over the last two
decades. Typically, the high-iron regions have a hypointense (dark)
signature on T2-weighted MR images and the presence of iron
also leads to signal changes in T2*-weighted gradient echo images.
The field-dependent rate increase (FDRI) technique, which
measures the difference in R2 at 1.5 and 0.5 T was found to
correlate strongly with iron concentration in healthy adults [15].
More recently, improved MRI techniques, such as susceptibil-
ity-weighted imaging (SWI) [16,17], is potentially useful for
the study of diseases with abnormal iron distributions. Several
previous studies have demonstrated correlations between SWI
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of healthy adults [18–20]. A postmortem validation study [21] also
has showed a linear correlation between R2* and brain iron
concentration. However, quantitative studies to verify the relation-
ship between R2*, phase values of SWI and brain-iron concentra-
tion have not universally agreed on the strength of the correlation.
In two reports, phase-sensitive methods did not correlate with iron
content, compared with R2 * [22] or FDRI technique [20].
Moreover, there is no report on the relationship between iron
concentration and magnitude SWI dataset, which is produced by
multiplying a phase mask image into the original magnitude image.
Both phase and magnitude sources of information complement
each other and are essential for proper tissue characterization,
hence, it is worthwhile to investigate the possibility of measuring the
iron level on the magnitude mapping.
Thus, in the current study, we measured both phase values and
R2* in each subject, and performed correlation analysis between
the two methods after combining with the previously published
iron concentrations [23]. We also proposed a new method using
magnitude signal intensity and compared it with R2* and brain
iron concentration.
Methods
Ethics Statement
All subjects had given written informed consent prior to the study
and the protocols had been approved by the human ethics
committee of the second affiliated hospital of Zhejiang university,
school of medicine. All clinical investigation has been conducted
according to the principles expressed in the Declaration of Helsinki.
Participants
Twenty-four healthy adults ranging in age 45 to 88 years
(mean=68.6, SD=11.3) participated in this study. The subjects
included 13 men (54.2%) and 11 women (45.8%). Subjects with a
history of neurological or psychiatric diseases, including head
trauma, were carefully excluded. The subjects with evidence of
focal parenchymal loss that might have resulted from infarct on
T2-weighted images, and space-occupying lesions were excluded
from further analysis.
MRI protocol
All MRI studies were performed on a 3.0 T system (Signa
Excite HD, General Electric Medical System, Milwaukee, USA)
equipped with an 8-channel phased array head coil. Foam pads
were inserted into the space between the subject’s head and the
MRI head coil to minimize head motion. Conventional T1- and
T2-weighted images were obtained for screening of space-
occupying lesions and cerebrovascular diseases in the study area,
especially the basal ganglia. The whole brain was imaged. The
susceptibility-weighted MR images were taken parallel to the
anterior–posterior commissural line and covered the nuclei of the
basal ganglia, using a three-dimensional gradient-echo sequence
with the following parameters: repetition time=58 ms; echo
time=20 ms; flip angle=20u; matrix size=2566256; FOV=
2406240 mm
2; slice thickness=2.0 mm with no gap between
slices, and in-plane spatial resolution of 0.468860.4688 mm/
pixel. Flow compensation was applied. Phase, magnitude and R2*
images were acquired and all of the data were used in further
analysis.
Image processing
The raw data were transferred to a separate workstation
(ADW4.4, GE) where the phase map, magnitude map and R2*
map were obtained by a home built program. In this study, we
used a high-pass filter with a central matrix size of 32632 to
remove background field inhomogeneities to create the corrected
phase image, which were described in detail elsewhere [16,19].
The phase values of the regions of interest (ROIs) were measured
on the corrected phase images, which ranged from 2p to +p. R2*
data were measured on the reconstructed R2* images. These two
methods were executed on the workstation.
As a new method of this study, the averaged signal intensities of
the ROIs were measured on the magnitude images. To remove
the individual differences of signal intensities, we then calculated
the relative magnitude signal intensity (RMSI) of ROIs by dividing
the mean magnitude signal intensity within each region by that of
frontal white matter (FWM) to derive MRI estimates of relative
iron content. These three pairs of data were used for comparison
between the three methods.
Image analysis
The ROIs included the bilateral red nucleus (RN), substantia
nigra (SN), globus pallidus (GP), putamen (PU), head of caudate
(CA), thalamus (TH) and frontal white matter (FWM). The basal
ganglia were chosen because it has a high iron content in the brain
and is easily visible on MR images [23,24]. TH and FWM were
selected to add regions of different amounts of iron.
The ROIs of the basal ganglia and thalamus were drawn
according to the anatomical structures and data for each nucleus
were obtained from all visible slices and both sides, except for
frontal white matter, where two consecutive slices were used. Four
measurements were done on the frontal white matter with a 20-
mm
2 square ROI and then averaged to obtain a final value. ROIs
on phase, R2* and magnitude images were exactly consistent by
drawing at the same time on the workstation (Figure 1 & 2).
Radiological Measurements
To demonstrate the reproducibility of the outlined ROIs of
three methods, one operator (S.Y.) drew the ROIs of 10 patients
twice, at an interval of 3 months apart. Another operator (J.S.)
independently drew the ROIs on the same patients.
Statistical analysis
We firstly calculated the descriptive statistics for the data of the
three methods. Since the RMSI measures of ROIs were skewed
towards the leftof mean, we performed natural log transformations of
RMSI measures before the correlation analysis. The log-transformed
RMSI (log(2RMSI)) appeared to be acceptably normative in each
brain region and all regions. To investigate the correlation of phase
value, R2*, and log(2RMSI) in each brain region and all regions,
bivariate (Pearson’s) correlation analysis was used depending on the
normality of the distribution, and bonferroni correction was used for
comparison between multiple groups. Statistical significance was set
at a probability value of #0.05. All statisticalanalyses wereperformed
using SPSS package (14.0 for Windows).
Results
The test-retest intraclass correlation coefficients for inter- and
intra-observer agreements were 0.967 and 0.923 respectively.
Because the intra- and inter-operator reliability measures were high,
onlyone measurement (S.Y.) was used for the remainder of the ROIs.
The values of three methods correlate with brain iron
levels
The phase values, R2*, and log(2RMSI) of each brain structure
are summarized in Table 1. As a check on the validity of three
MRI Evaluation of Brain Iron Content
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iron concentrations in different regions, as previously measured by
biochemical methods [23], and the phase values, R2*, log(2-
RMSI), respectively. A strong positive correlation was found
between R2* and previously published iron concentrations [23] in
seven brain regions (r=0.984, P,0.001) (Figure 3A). The results
also showed a strong inverse correlation between the calculated
log(2RMSI) and iron concentrations (r=20.982, p,0.001)
(Figure 3C). However, there was no significant correlation be-
tween phase value and iron concentrations (r=20.693, p=0.084)
(Figure 3B).
Correlation between R2* and phase values
Correlation analysis of the phase values were performed with
R2* of each brain region, a total number of 168 samples. The
result showed a significant correlation in all regions (r=20.594,
P,0.001) (Figure 4A). To investigate the reason of no correlation
between phase value and chemical brain iron content, we analyzed
the correlation between phase values and R2* in four iron-
rich regions (red nucleus, substantia nigra, globus pallidus and
putamen). Table 1 showed correlations in substantia nigra
(r=20.723, p,0.001) and putamen (r=20.514, p=0.010), while
no significant correlations in red nucleus (r=20.236, p=0.268)
and globus pallidus (r=20.111, p=0.605).
Correlation between R2* and log(2RMSI)
A similar analysis was performed between log(2RMSI) and
R2*. The results showed a strong correlation in 144 brain regions
(r=20.851, P,0.001) (Figure 4B). Table 1 showed significant
correlations in the four iron-rich regions, red nucleus (r=20.593,
p=0.002), substantia nigra (r=20.521, p=0.009), globus pallidus
(r=20.750, p,0.001) and putamen (r=20.547, p=0.006).
Discussion
In this study, we showed a strong linear correlation between
R2* and iron concentrations reported by Hallgren and Sourander
and found that R2* correlated best with iron concentrations in the
human brain. This finding is consistent with recent postmortem
study which indicated that R2* is more sensitive than R2 to
variations in brain iron concentration [21], and thus lend further
support to select R2* as a sensitive marker for iron in brain tissue.
We did not find a significant correlation between phase values
and iron concentrations in seven brain regions in the current
Figure 1. Illustration of the selected regions of interest. (A), The selected ROIs of the corrected phase images. (B), The selected ROIs of the R2*
images. (C), The selected ROIs of the magnitude images. 1=caudate; 2=putamen; 3=globus pallidus; 4=thalamus.
doi:10.1371/journal.pone.0031748.g001
Figure 2. Illustration of the selected regions of interest. (A), The selected ROIs of the corrected phase images. (B), The selected ROIs of the R2*
images. (C), The selected ROIs of the magnitude images. 5=red nucleus; 6=substantia nigra.
doi:10.1371/journal.pone.0031748.g002
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brain [21,23] was lower than RN, SN, PU and even CA when
detected by phase value. Similar findings was also shown in
another study where iron content in GP was lower than RN and
SN, and was close to the concentration in CA when phase value
was used as the brain iron index [25]. These findings indicated
that phase value should be used with reservation in evaluating the
brain iron content. When we further compared the relationship
between phase value and R2*, we found an inverse correlations in
SN and PU, while no correlations in RN and GP. This implies that
phase value in GP may not be an appropriate marker for in vivo
brain iron content, but may be acceptable to assess iron level in
SN, which plays an important role in Parkinson’s disease [26–28].
In principle, the quantification of iron content or its
susceptibility from phase images has limitations. The Fourier
transform of susceptibility cannot be accurately determined in
regions near the conical surfaces of magic angle [29,30]. From the
equation between iron content and phase value [31], one can
deduce that the phase value changes with the difference of the
magnetic susceptibility of the surrounding tissue of interest, besides
the iron content. Phase value is thus related to the non-local
distribution of iron and can be compromised by its dependence on
object orientation.
The results of this study confirmed that the new index for
evaluating the brain iron content (log(2RMSI)) based on
magnitude images correlated well with R2* in all measured
regions, especially in globus pallidus. They also showed a strong
correlation with the reported iron concentrations throughout the
brain. Since the amount of iron in the human body is
approximately 30 times that of all other transition elements
combined, the paramagnetic effect is mostly caused by iron.
Moreover, iron not only changes the relaxation of tissue water
surrounding ferritin but also introduces changes of susceptibility
and microscopic field gradients. The magnitude signal intensity
response for the gradient-echo sequence is given by:
rm(h)~r0:sinh:exp({R2  :TE): 1{exp({TR=T1)
1{cosh:exp({TR=T1)
,
where r0 is the tissue spin density, TR is the repeat time of each
data acquisition, T1 is the tissue longitudinal relaxation time, and
h is the angle by which the magnetization is tipped (usually called
the flip angle). Scaling by the frontal white matter intensity may
remove the signal dependence on flip angle and small T1 effect.
Therefore, this signal equation explains the strong inverse
correlation between log(2RMSI) and R2*. The development of
the RMSI index in the region of interest compared to frontal white
matter may have utility in clinical research, by eliminating the
absolute value of the susceptibility changes from subject to subject.
Recently, similar analysis was done based on a brain atlas-based
T2 relaxation time map [32]. However, in their study, they
contrasted it with FDRI and magnetic field correlation (MFC)
values, but not with R2*. It might be interesting to compare our
log(2RMSI) with this approach in the future study.
There are limitations to our study that need to be considered
when interpreting our findings. First, independent histopatholog-
ical confirmation of the three methods was not available. We
compared the three indexes with the previous published iron
concentrations. Therefore, it is important to point out that the
correlation of brain iron content with three methods is an
assumption of the approach. The methods should be further
examined with both histopathological analysis and MRI scans in
Table 1. R2*, phase values and log(2RMSI) (mean6SD) for each brain structure.
Brain regions R2* phase value Correlation
& log(2RMSI) Correlation
#
red nucleus 35.1866.90 20.149160.0709 r=20.236, p=0.268 20.491960.1743 r=20.593, p=0.002
substantia nigra 37.7968.15 20.309360.1488 r=20.723, p,0.001 20.602860.1883 r=20.521, p=0.009
globus pallidus 43.1567.44 20.088060.0605 r=20.111, p=0.605 20.581160.1549 r=20.750, p,0.001
putamen 30.6064.68 20.119660.0662 r=20.514, p=0.010 20.313460.1050 r=20.547, p=0.006
all measured regions 29.41610.75 20.108760.1258 r=20.594, p,0.001 20.366460.2571 r=20.851, p,0.001
Notes.
&Correlation between phase values and R2*.
#Correlation between log(2RMSI) and R2*.
doi:10.1371/journal.pone.0031748.t001
Figure 3. The Scatter plots between three methods and brain iron concentration as published. (A), The correlation between R2* and
brain iron concentrations. (B), The correlation between phase values and brain iron concentrations. (C), The correlation between log(2RMSI) and
brain iron concentration. CA=caudate; PU=putamen; GP=globus pallidus; TH=thalamus; RN=red nucleus; SN=substantia nigra; FWM=frontal
white matter.
doi:10.1371/journal.pone.0031748.g003
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variety of factors other than the presence of magnetic iron
particles, such as regional tissue characteristics and imaging
parameters include voxel size, field strength and echo time. This
limitation may also find in other techniques, such as FDRI
technique that further requires the use of two different field-
strength MRI instruments. Third, the calcification in the brain
tissue may be confused with iron deposits in these measurements.
The new quantitative susceptibility mapping technique by solving
the field to susceptibility source inverse problem is promising to
address the second and third limitations [30].
In conclusion, we analyzed the relationship between three
methods used for assessing the brain iron content, including phase
value, R2* and log(2RMSI), and we found that R2* and
log(2RMSI) are both good markers, while phase value has
limitations. Future prospective studies using more advanced MRI
techniques and postmortem studies to confirm our findings.
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